Pathomorphological Sequence of Nephron Loss in Diabetic Nephropathy.
暂无分享,去创建一个
F. Bestvater | H. Gröne | W. Kriz | M. Gross-Weissmann | E. Gröne | Jana Löwen | Marie-Luise Gross-Weissmann
[1] R. Dong,et al. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A. , 2019, American journal of physiology. Renal physiology.
[2] H. Gröne,et al. Herniation of the tuft with outgrowth of vessels through the glomerular entrance in diabetic nephropathy damages the juxta-glomerular- apparatus. , 2019, American journal of physiology. Renal physiology.
[3] K. Rahman,et al. CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway , 2019, Front. Pharmacol..
[4] S. Lipton,et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 , 2018, Cell Death & Differentiation.
[5] A. Shaw,et al. Injury-induced actin cytoskeleton reorganization in podocytes revealed by super-resolution microscopy. , 2017, JCI insight.
[6] K. Endlich,et al. Stressed podocytes—mechanical forces, sensors, signaling and response , 2017, Pflügers Archiv - European Journal of Physiology.
[7] H. Gröne,et al. The hormetic functions of Wnt pathways in tubular injury , 2017, Pflügers Archiv - European Journal of Physiology.
[8] H. Gröne,et al. Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy. , 2017, American journal of physiology. Renal physiology.
[9] K. Lemley,et al. Potential relevance of shear stress for slit diaphragm and podocyte function. , 2017, Kidney international.
[10] Daohai Zhang,et al. Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway , 2016, Journal of Molecular Medicine.
[11] A. Koster,et al. Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy , 2016, Diabetes.
[12] T. B. Huber,et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis , 2015, Autophagy.
[13] H. Anders,et al. Glomerular parietal epithelial cell activation induces collagen secretion and thickening of Bowman’s capsule in diabetes , 2015, Laboratory Investigation.
[14] Zhihong Liu,et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease. , 2015, American journal of physiology. Renal physiology.
[15] B. Levine,et al. Autosis and autophagic cell death: the dark side of autophagy , 2014, Cell Death and Differentiation.
[16] N. Gretz,et al. Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure , 2014, The Journal of pathology.
[17] A. Advani,et al. Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes , 2013, Diabetes.
[18] B. Kaissling,et al. Renal epithelial injury and fibrosis. , 2013, Biochimica et biophysica acta.
[19] Kevin V Lemley,et al. The podocyte's response to stress: the enigma of foot process effacement. , 2013, American journal of physiology. Renal physiology.
[20] B. Smeets,et al. Parietal epithelial cells and podocytes in glomerular diseases. , 2012, Seminars in nephrology.
[21] S. Satchell,et al. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability , 2012, The Journal of pathology.
[22] H. Anders,et al. Tumour necrosis factor‐α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis , 2012, The Journal of pathology.
[23] Hyun Soon Lee. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease , 2011, Cell and Tissue Research.
[24] M. Schiffer,et al. The role of metabolic and haemodynamic factors in podocyte injury in diabetes , 2011, Diabetes/metabolism research and reviews.
[25] M. Lotze,et al. The Beclin 1 network regulates autophagy and apoptosis , 2011, Cell Death and Differentiation.
[26] M. Le Hir,et al. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? , 2011, The Journal of clinical investigation.
[27] J. Sowers,et al. Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. , 2010, American journal of physiology. Renal physiology.
[28] P. Mundel,et al. Dual effects of RAS blockade on blood pressure and podocyte function , 2007, Current hypertension reports.
[29] C. Cohen,et al. Collagen type VIII expression in human diabetic nephropathy , 2007, European journal of clinical investigation.
[30] S. Harper,et al. A Role for the Endothelial Glycocalyx in Regulating Microvascular Permeability in Diabetes Mellitus , 2007, Cell Biochemistry and Biophysics.
[31] R. Heine,et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. , 2006, Diabetes.
[32] W. Kriz,et al. Pathways to nephron loss starting from glomerular diseases-insights from animal models. , 2005, Kidney international.
[33] D. Suzuki,et al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] M. Le Hir,et al. A novel mechanism of nephron loss in a murine model of crescentic glomerulonephritis. , 2003, Kidney international.
[35] K. Sharma,et al. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Osterby,et al. Neovascularization at the vascular pole region in diabetic glomerulopathy. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[37] G. Crepaldi,et al. Patterns of renal injury in NIDDM patients with microalbuminuria , 1996, Diabetologia.
[38] W. Kriz,et al. Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. , 1995, Kidney international.
[39] E. Whorton,et al. Insudative lesions--their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypothesis based on single views of advancing human diabetic nephropathy. , 1994, Human pathology.
[40] W. Kriz,et al. The contractile apparatus of podocytes is arranged to counteract GBM expansion. , 1994, Contributions to nephrology.
[41] W. Kriz,et al. A role for podocytes to counteract capillary wall distension. , 1994, Kidney international.
[42] M. Steffes,et al. Renal interstitial expansion in insulin-dependent diabetes mellitus. , 1993, Kidney international.
[43] S. Nishi,et al. An electron microscopic study of glomeruli in Japanese patients with non-insulin dependent diabetes mellitus. , 1992, Kidney international.
[44] C. Abrass,et al. Phenotypic Expression of Collagen Types in Mesangial Matrix of Diabetic and Nondiabetic Rats , 1988, Diabetes.
[45] A. Cerami,et al. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. , 1984, Annals of internal medicine.
[46] G. Viberti. Increased capillary permeability in diabetes mellitus and its relationship to microvascular angiopathy. , 1983, American Journal of Medicine.
[47] A. Michael,et al. Immunopathology of Renal Extracellular Membranes in Diabetes Mellitus: Specificity of Tubular Basement-membrane Immunofluorescence , 1976, Diabetes.
[48] R. Vracko. Basal Lamina Layering in Diabetes Mellitus: Evidence for Accelerated Rate of Cell Death and Cell Regeneration , 1974, Diabetes.
[49] F. Walker,et al. The origin, turnover and removal of glomerular basement‐membrane , 1973, The Journal of pathology.
[50] J. Pascual,et al. Renin-angiotensin system within the diabetic podocyte. , 2015, American journal of physiology. Renal physiology.
[51] J. Nyengaard,et al. Development of renal structural lesions in type-1 diabetic patients with microalbuminuria , 2014, Virchows Archiv.
[52] J E Tooke,et al. High glucose causes dysfunction of the human glomerular endothelial glycocalyx. , 2011, American journal of physiology. Renal physiology.
[53] R. Gebhardt,et al. Cardiovascular , Pulmonary and Renal Pathology Tubular Overexpression of Transforming Growth Factor-1 Induces Autophagy and Fibrosis but Not Mesenchymal Transition of Renal Epithelial Cells , 2010 .
[54] F. Ziyadeh. Renal tubular basement membrane and collagen type IV in diabetes mellitus. , 1993, Kidney international.
[55] P. Kimmelstiel,et al. Thickness of glomerular basement membranes. , 1966, American journal of clinical pathology.
[56] N. Wahab,et al. J Am Soc Nephrol 14: 1358–1373, 2003 Extracellular Matrix Metabolism in Diabetic Nephropathy , 2022 .